Clinical trial
Implementation of the US PRECISION AIRQ, Asthma Checklist, and Educational Resources (PRECISION Program) Into Clinical Practice Using Telehealth and In-Person Platforms
NCT04891978 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Implementation of the US PRECISION AIRQ, Asthma Checklist, and Educational Resources (PRECISION Program) Into Clinical Practice Using Telehealth and In-Person Platforms
- Lead sponsor
- AstraZeneca
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 20, 2021
- Completion date
- April 30, 2023
- Enrollment
- 857 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.